Inactive Instrument

Highlights Atlas Cloud Enterprises Inc Canadian Securities Exchange

Equities

AKE

CA0492371004

End-of-day quote Canadian Securities Exchange Other stock markets
-	-

Jan. 23	Isracann Biosciences Inc. Announces Management Changes	CI
Jan. 23	Isracann Biosciences Inc. Announces Resignation of Yana Popova as CFO	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Isracann Biosciences Inc. Reports Earnings Results for the First Quarter Ended August 31, 2022	22-12-07	CI
Isracann Biosciences Inc. Reports Earnings Results for the Full Year Ended May 31, 2022	22-11-29	CI
Isracann Bioscience Inc. Announces Facilitated Genetics Arrive in Israel	22-09-28	CI
Isracann Bioscience Facilitates Cannabis Genetics Shipment to Israel	22-09-14	CI
Isracann Inks Distribution Agreement with Pure Integrative Pharmacy for Praesidio Health Products	22-09-01	MT
Isracann Biosciences Inc. Signs Distribution Agreement with Pure Integrative Pharmacy	22-09-01	CI
Isracann Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	22-04-27	CI
Isracann Biosciences Inc. completed the acquisition of Praesidio Health Inc.	22-04-11	CI
Isracann Biosciences Inc. entered into a binding Letter of Intent to acquire Praesidio Health Inc. for CAD 4 million.	22-02-22	CI
Isracann Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2021	22-01-31	CI
Isracann Biosciences Inc. Reports Earnings Results for the First Quarter Ended August 31, 2021	21-10-28	CI
Isracann Biosciences Inc. Receives Foreign Owners License	21-10-20	CI
Isracann Biosciences Inc. Updates on Its Phase Two Facility Construction	21-10-20	CI
Isracann Biosciences Inc. Completes Phase One Construction At Cannabis Facility in Israel	21-10-20	CI
Isracann Biosciences Inc. Enters Non-Binding Letter of Intent Outlining an Importation Sales Agreement with Major Israeli Medical Cannabis Compan	21-10-20	CI
Isracann Prepares to Import Canadian Cannabis into Israel and Europe; Entered into an Agreement with United Greeneries Ltd. to Export Canadian Cannabis into Israel and with Non-Exclusive Agreement for Entry into the European Markets	21-10-20	CI
Isracann Biosciences Inc. Reports Earnings Results for the Full Year Ended May 31, 2021	21-09-29	CI
Isracann Biosciences Inc. Reports Earnings Results for the Third Quarter Ended February 28, 2021	21-04-29	CI
Isracann Receives Foreign Owners License and Updates Israeli Cannabis Operations	21-04-21	CI
Isracann Biosciences Inc. Completes Phase One Construction At Cannabis Facility in Israel	21-02-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Atlas Cloud Enterprises Inc Canadian Securities Exchange

Equities

AKE

CA0492371004

Highlights

Filters